20 likes | 113 Views
"Suppl. Fig. 2: Assessment of CRM197-specific T cell responses using ELISPOT analysis with PBMCs post-Prevnar vaccination. Comparison of IFN-γ responses between Arm 1 (no cyclophosphamide) and Arm 2. Y-axis scale differences indicated. Reference line at 50 spot forming cells."
E N D
Suppl Fig. 2 CRM197 specific T cell responses as determined by ELISPOT. Longitudinal assessment of IFN-γ responses to CRM-197 carrier protein. ELISPOT analysis was performed using PBMCs obtained at time points post Prevnar vaccination against the carrier protein CRM197. Composite plots for Arm 1 patients receiving no cyclophosphamide and Arm 2 no cyclophosphamide are depicted; note differences in y-axis scale. A reference line (black dotted line) indicating 50 spot forming cells is shown.